SAN FRANCISCO BAY AREA, Calif. — 10x Science, which builds frontier AI for molecular-level protein characterization across the life sciences, today announced the closing of its $4.8M seed round led by Initialized Capital. The oversubscribed round includes investments from Y Combinator, Civilization Ventures, Founder Factor, and a group of strategic angel investors. Starting with drug […]
VANCOUVER, British Columbia — ViewsML, a company building the computational layer for biomarker discovery by transforming tissue analysis from a lab process into software, today announced the completion of an oversubscribed $4.9M seed funding round led by Wittington Ventures. Additionally, new investors Continuum Health Ventures and Mayo Clinic contributed alongside repeat investors RiSC Capital, Debiopharm, […]
Founded by deep scientific experts across biomedical engineering, stem cell biology and organoid systems Funding round led by First Star Ventures CHAPEL HILL, N.C. — iOrganBio today announced its launch from stealth with $2 million in funding to transform how human cells are made. The round was led by First Star Ventures along with institutional […]
New funding will expand Cytely’s smart‑microscopy platform, moving research from linear progress to self-accelerating discovery. LUND, SWEDEN — Cytely today announced new funding led by Ugly Duckling Ventures to expand availability of its smart-microscopy platform and accelerate the mission to cure all preventable disease. Cytely’s hardware-agnostic smart‑microscopy platform converts microscopes into real‑time data engines, eliminating manual […]
EPFL spin-off Bioscibex, a biotech hardware startup developing advanced single-use bioreactors, has secured CHF 150,000 in funding from Venture Kick. The financing will accelerate the commercialization of its first product, Swingo, designed to simplify and automate cell culture, making biologic therapies more accessible. Biologics have revolutionized the treatment of cancer, autoimmune disorders, and other severe […]
SOMERVILLE, Mass. — Matterworks, Inc., the category-defining pioneer unlocking unstructured molecular data for predictive biology, today announces new Series A financing. The round was led by Lewis & Clark Partners and OMX Ventures, joined by Pillar VC, Germin8 Ventures, Intermountain Ventures, and Tarsadia, among others. The Company will use its Series A proceeds to grow […]
PARIS — Okomera announces Bpifrance funding to develop and standardize novel CRISPR screening assay to accelerate drug discovery in oncology with leading cancer research center of Marseille, CRCM. Okomera is developing desktop platform for automated organoid screening using droplet-microfluidics and AI to accelerate drug discovery. Their patented tech developed after 10 years of research at Pasteur Institute and […]
The San Francisco-based company with an R&D facility in Bilbao has also unveiled its Platforma.bio Software Development Kit, transforming how biologists analyze genomic data to drive drug discovery and advance adjacent fields in medicine. This latest financing bolsters the company’s efforts to transform computational biology on a global scale and empower researchers with innovative tools […]
With Briefly Bio scientists no longer need to reinvent the wheel – spending time and resources on experiments that they can’t reproduce. This will enable scientists to produce datasets that will quickly expand our understanding of biology. London, UK – Science is in a reproducibility crisis. In preclinical research, it’s estimated that over 50% of efforts […]
SAN DIEGO — Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, proudly announces the successful completion of a $7.5 million Series A funding round. This funding, led by Genoa Ventures with participation from FusionX Ventures and Vertical Venture Partners, is complemented by two ongoing SBIR grants totaling $4 million from The National Human Genome Research […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
